Summaries for Acromegaly

Sources:
6Disease Ontology, 30NIH Rare Diseases, 44Wikipedia, 33OMIM, 22MalaCards
See all sources

Export this MalaCard
NIH Rare Diseases: Acromegaly is a hormonal disorder that results from the pituitary gland producing too much growth hormone (GH). It is most often diagnosed in middle-aged adults, although symptoms can appear at any age. Signs and symptoms include abnormal growth and swelling of the hands and feet; bone changes that alter various facial features; arthritis; carpal tunnel syndrome; enlargement of body organs; and various other symptoms. The condition is usually caused by benign tumors on the pituitary called adenomas. Rarely, it is caused by tumors of the pancreas, lungs, and other parts of the brain. Acromegaly is usually treatable but when left untreated, it can result in serious illness and premature death. When GH-producing tumors occur in childhood, the disease that results is called gigantism rather than acromegaly.30

MalaCards: Acromegaly, also known as growth hormone excess, is related to mccune albright syndrome and cushing's syndrome. An important gene associated with Acromegaly is GH1 (growth hormone 1), and among its related pathways are Development_Leptin signaling via JAK/STAT and MAPK cascades and Glioma Invasiveness. The drugs bromocriptine and bromocriptine mesylate and the compounds 25-hydroxyvitamin d and 17-hydroxyprogesterone have been mentioned in the context of this disorder. Affiliated tissues include limb, brain and heart, and related mouse phenotypes are hematopoietic system and endocrine/exocrine gland.

Disease Ontology: A disease of metabolism that has material basis in excessive growth hormone production which results in enlargement located in limb.6

Wikipedia: Acromegaly (pron.: /ˌækrɵˈmɛɡəli/; from Greek άκρος akros \"extreme\" or \"extremities\" and...44 more...

OMIM: 102200

Aliases & Descriptions for Acromegaly

Sources:
6Disease Ontology, 7diseasecard, 30NIH Rare Diseases, 8DISEASES, 33OMIM, 32Novoseek , 43UMLS, 40SNOMED-CT, 24MeSH, 27NCIt
See all sources

Aliases & Descriptions:

acromegaly 6 7 30 8 33 32 43
growth hormone excess 30
somatotroph adenoma 30
pituitary giant 30

External Ids:

Related Diseases for Acromegaly

Sources:
13GeneCards, 14GeneDecks
See all sources

Diseases related to acromegaly by text searches and GeneDecks gene sharing:

(show top 50)    (show all 997)
idRelated DiseaseScoreTop Affiliating Genes
1mccune albright syndrome31.8APC, GNAS, GH1, PRL
2cushing's syndrome31.4SCG5, HSD11B2, GH1, SST, CRH, POMC
3acid-labile subunit31.2APOA1, IGFBP5, IGFBP1, IGF2, IGFBP2, IGFALS
4pituitary tumor30.2CNC, VIP, PBX1, SCG5, LEPR, CHGA
5breast cancer29.6CDKN1B, APC, IGFBP5, GHR, CTSD, EGF
6hypertension29.5CYP11B2, ACE, AGT, AGTR1, ADRB2
7neuroendocrine tumor29.5GCG, VIP, CHGA, MEN1, CCK, GNAS
8carney complex29.4CNC, CHGA, CDKN1B, MEN1, GNAS, GH1
9diabetic ketoacidosis29.2BGLAP, INS, IL6, ALB, CALCA, SST
10growth hormone secreting pituitary adenoma29.0VEGFA, CGB, MEN1, IGF1, GNAS, GH1
11hyperprolactinemia28.9VIP, BRD2, BGLAP, CGB, INS, IL6
12multiple endocrine neoplasia28.8CNC, GCG, VIP, PBX1, CHGA, CDKN1B
13growth disorders28.4CGB, IGF2, IGFBP3, IGF1, GH1, GHR
14somatostatin analog, resistance to28.3IGF1, SST, SSTR5
15turner syndrome28.1BGLAP, CGB, IGFBP1, IGFBP3, IGF1, GH1
16polycystic ovary syndrome28.0LEP, INS, INSR, IGFBP1, IGF2, IGFBP2
17fibrous dysplasia27.9BGLAP, CD36, IL6, APC, GNAS, CALCA
18sleep apnea27.8RETN, LEP, GHR, LSL, NPPB, NPY
19pancreatic islet cell tumors27.8VIP, CHGA, INS, MEN1, IGF2, CALCA
20familial isolated hyperparathyroidism27.7MEN1, PTH, GAST
21acanthosis nigricans27.6LEP, INS, INSR, IGF1, GH1, SHBG
22glucose intolerance27.4GCG, MLN, APOB, CCK, GHRL, PYY
23gigantism27.3LPA, CD36, INS, MEN1, IL6, APOA1
24prolactinoma27.2VIP, PBX1, BGLAP, CHGA, CGB, INS
25pituitary carcinoma27.0CHGA, GHRH, TP53, SST, SSTR2, CRH
26carcinoid syndrome26.7VIP, VEGFA, CHGA, MLN, MEN1, IGF1
27congestive heart failure26.7CYP11B2, EDN1, ACE, AGT, AGTR1, NPPB
28hypopituitarism26.5GCG, BRD2, PBX1, LEP, INS, IL6
29growth hormone deficiency26.5RETN, SERPINE1, VIP, LPA, LPL, PBX1
30arthritis25.8VIP, IL6, IL8, TNF
31prostate disease25.7IGFBP3, IGF1, ALB, GH1, CTSD, PPARG
32carcinoid tumors25.7GCG, VIP, CHGA, CGB, MEN1, APC
33liver cirrhosis25.5RETN, GCG, RBP4, SERPINC1, VIP, LPA
34pituitary adenoma24.5CNC, VIP, VEGFA, PBX1, SCG5, LEP
35headache24.5VIP, INS, IL1RAPL2, IL1RN, IL6, IGF1
36type 1 diabetes mellitus24.4RETN, GCG, RBP4, NAGLU, LPA, PBX1
37hypogonadism23.8RETN, GC, SERPINC1, SERPINE1, BRD2, RAB18
38hyperandrogenism23.4RETN, NAMPT, BRD2, LEP, CD36, INS
39lipodystrophy23.3RETN, RBP4, SERPINE1, NAMPT, LPA, LPL
40myopathy22.8BRD2, LEP, INS, INSR, IL1RAPL2, IL1RN
41hypoglycemia22.2GCG, BRD2, VEGFA, LPL, LEP, CHGA
42insulin resistance21.5RETN, GCG, RBP4, SERPINE1, NAGLU, NAMPT
43adenoma21.4RETN, CNC, GCG, VIP, BRD2, VEGFA
44meningioma21.0SERPINC1, SERPINE1, VEGFA, SCG5, LEP, CDKN1B
45apnea20.9RETN, RBP4, SERPINE1, NAMPT, LPL, LEP
46aldosteronism20.6RETN, SERPINE1, VIP, NAGLU, NAMPT, VEGFA
47lateral sclerosis20.2SERPINE1, VEGFA, LPA, LPL, CHGA, MMP2
48osteosarcoma19.8GC, SERPINC1, SERPINE1, VEGFA, LPL, BGLAP
49hyperparathyroidism19.8GC, SERPINE1, VIP, VEGFA, PBX1, BGLAP
50osteoporosis19.4GCG, GC, RBP4, SERPINC1, BRD2, VEGFA

Graphical network of the top 20 diseases related to acromegaly:



Graphical network of diseases related to acromegaly

Clinical Features for Acromegaly

Sources:
33OMIM
See all sources
Clinical features from OMIM: 102200

Drugs & Therapeutics for Acromegaly

Sources:
4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT
See all sources

Approved drugs:

Search CenterWatch for acromegaly

Drug clinical trials:

Search ClinicalTrials for acromegaly

Search NIH Clinical Center for acromegaly

Search CenterWatch for acromegaly

Inferred drug relations via UMLS/NDF-RT:

43 28 bromocriptine, bromocriptine mesylate, octreotide, octreotide acetate, pegvisomant

Genetic Tests for Acromegaly

Anatomical Context for Acromegaly

Sources:
11FMA, 22MalaCards
See all sources

MalaCards organs/tissues related to acromegaly:

22
Brain, Heart, Skeletal muscle, Small intestine, Colon, Liver, Lung, Pancreas, Thyroid, Salivary gland, Adrenal gland, Skin, Ovary, Prostate, T cells, B cells, Endothelial, Fetal brain, Tongue, Fetal liver, Fetal thyroid, Pancreatic islet, Pituitary

FMA organs/tissues related to acromegaly:

11
Limb

Phenotypes for genes affiliated with Acromegaly

Sources:
25MGI
See all sources

MGI Mouse Phenotypes related to acromegaly:

25 (show all 27)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1hematopoietic system phenotypeMP:000539710.4IGF2, PTH, SSTR4, TG, PRKAR1A, POU1F1
2endocrine/exocrine gland phenotypeMP:000537910.1PTH, CYP11B2, CORT, PRKAR1A, POU1F1, GAL
3respiratory system phenotypeMP:000538810.0PRKAR1A, PLAGL1, CRH, SSTR4, DRD2, CALCA
4embryogenesis phenotypeMP:00053809.7TFPI, PRLR, PRKAR1A, PRL, PLAGL1, AIP
5craniofacial phenotypeMP:00053829.5POU1F1, PRKAR1A, TFPI, EDN1, PTH, DYM
6renal/urinary system phenotypeMP:00053679.5NAGLU, PBX1, LEPR, CHGA, CFI, CDKN1B
7limbs/digits/tail phenotypeMP:00053719.4DYM, DRD2, PTH, PLAGL1, TFPI, PRLR
8pigmentation phenotypeMP:00011869.2POMC, PRKAR1A, DRD2, TP53, APOB, APC
9integument phenotypeMP:00107719.0PBX1, SCG5, LEPR, CDKN1B, APC, GNAS
10normal phenotypeMP:00028738.5GHRL, PYY, SST, CRH, CORT, THBD
11no phenotypic analysisMP:00030128.5TP53, DRD2, SST, SSTR3, SSTR4, PPARG
12reproductive system phenotypeMP:00053898.3VIP, DRD2, AGT, PRKAR1A, PRL, POU1F1
13digestive/alimentary phenotypeMP:00053818.3HSD11B2, GHRL, GHSR, DRD2, SST, SSTR2
14liver/biliary system phenotypeMP:00053708.0RETN, SERPINC1, BRD2, VEGFA, LPL, PBX1
15nervous system phenotypeMP:00036318.0BRD2, PBX1, SCG5, CD36, CDKN1B, MMP2
16immune system phenotypeMP:00053877.6GHR, GAST, ADIPOQ, ADRB2, TP53, TNF
17tumorigenesisMP:00020067.5TNF, DRD2, PPARG, ACE, PRLR, PRKAR1A
18behavior/neurological phenotypeMP:00053867.4VIP, NAGLU, BRD2, PBX1, SCG5, LEP
19skeleton phenotypeMP:00053907.1PBX1, LEP, LEPR, MMP2, INS, IL6
20adipose tissue phenotypeMP:00053756.8GHR, ADIPOQ, ADRB2, NPY, POMC, GHRHR
21growth/size phenotypeMP:00053786.2GCG, SERPINE1, NAGLU, BRD2, LPL, PBX1
22vision/eye phenotypeMP:00053916.1CTSD, SSTR2, SSTR1, TNF, TP53, PPARG
23muscle phenotypeMP:00053695.8PPARG, CYP11B2, DRD2, TNF, TP53, HSD11B2
24mortality/agingMP:00107685.4PLAGL1, PPARG, CTSD, CYP11B2, PTH, DRD2
25cellular phenotypeMP:00053845.4CRH, PPARG, CTSD, SSTR1, CYP11B2, DRD2
26cardiovascular system phenotypeMP:00053853.2EDN1, ADIPOQ, ACE, AGT, AGTR1, THBD
27homeostasis/metabolism phenotypeMP:00053761.6CORT, ADCY10, ADIPOQ, GAL, GAST, ADRB2

Publications for genes affiliated with Acromegaly

Sources:
35PubMed
See all sources

Articles related to acromegaly:

(show top 50)    (show all 663)
idTitleAuthorsYearAffiliating Genes
1Prevalence of AIP mutations in a large series of spor adic Italian acromegalic patients and evaluation of CDKN1B status in acromegali c patients with multiple endocrine neoplasia. (20530095)Occhi G.... Scaroni C.2010CDKN1B, AIP
2Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naA^ve to radiation and medical therapy. (20009494)Ghigo E.... Klibanski A.2009IGF1, IGFBP3
3Acromegaly: correlation between expression of somatos tatin receptor subtypes and response to octreotide-lar treatment. (19330452)Casarini A.P.... Bronstein M.D.2009SSTR2, SSTR3, SSTR5
4Monitoring of acromegaly: what should be performed wh en GH and IGF-1 levels are discrepant? (19226264)Freda P.U.2009IGF1
5Combined acromegaly and subclinical Cushing disease related to high-molecular-weight adrenocorticotropic hormone. (18991502)Oki K.... Kohno N.2009IGF1
6Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register. (19226273)Petersenn S.... Reincke M.2009IGF1, GH1
7Acromegaly (19004612)Chanson P.2009SST
8Significant tumour shrinkage after 12 months of lanre otide Autogel-120 mg treatment given first-line in acromegaly. (19094074)Colao A.... Ferone D.2009GH1
9Somatostatin analog and pegvisomant combination thera py for acromegaly. (19763127)Neggers S.J.... van der Lely A.J.2009IGF1, SST
10Clinical and molecular genetics of acromegaly: MEN1, Carney complex, McCune-Albright syndrome, familial acromegaly and genetic defects in sporadic tumors. (18200440)Horvath A.... Stratakis C.A.2008MEN1
11Acromegaly, growth hormone and cancer risk. (18971124)Renehan A.G.... Brennan B.M.2008IGF1
12Results of surgical and somatostatin analog therapies and their combination in acromegaly: a retrospective analysis of the German Acromegaly Register. (18755874)Petersenn S.... PlAPckinger U.2008SST
13Remission of acromegaly following long-term therapy with cabergoline: report of two cases. (17530416)Verhelst J.A.... Abs R.2008IGF1, GH1
14Improvement of endothelial dysfunction in acromegaly after transsphenoidal surgery. (18506091)Sakai H.... Hirata Y.2008IGF1, INS, GH1
15Impact of treating acromegaly first with surgery or somatostatin analogs on cardiomyopathy. (18445662)Colao A.... Lombardi G.2008GH1
16The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients. (17652220)Colao A.... Lombardi G.2007INS
17Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly. (17309144)Gradiser M.... Vrkljan M.2007IGF1, GH1
18Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients. (17541749)Biermasz N.R.... Roelfsema F.2007SST
19Perioperative plasma active and total ghrelin levels are reduced in acromegaly when compared with in nonfunctioning pituitary tumours even after normalization of serum GH. (17466003)Kawamata T.... Hori T.2007GHRL
20Growth hormone (GH) receptor isoform in acromegaly: lower concentrations of GH but not insulin-like growth factor-1 in patients with a genomic deletion of exon 3 in the GH receptor gene. (17573420)Schmid C.... Wiesli P.2007IGF1, GHR, GH1
21Long-term primary medical therapy with somatostatin analogs in acromegaly. (16935768)Su D.H.... Chang T.C.2006SST
22Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. (16403824)Jenkins P.J.... Wass J.A.2006IGF1, GH1
23The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly. (16118335)Bhayana S.... Ezzat S.2005IGF1, SST, GH1
24GH and mortality in acromegaly. (16625851)Sheppard M.C.2005GH1
25Cardiovascular complications in acromegaly. (15282442)Vitale G.... Colao A.2004GH1
26The role of somatostatin receptors in the medical treatment of acromegaly. (15077912)Vitale G.... Colao A.2004SSTR2, SSTR5, SST
27Serum adiponectin is reduced in acromegaly and normalized after correction of growth hormone excess. (15531496)Lam K.S.... Tam S.2004INS
28The role of growth hormone-receptor antagonism in relation to acromegaly. (15500374)Ayuk J.... Sheppard M.C.2004GHR
29Ghrelin administration affects circulating pituitary and gastro-entero-pancreatic hormones in acromegaly. (14713276)Arosio M.... Peracchi M.2004POMC, PRL, PBX1
30Significance of 'abnormal' nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels. (14764751)Freda P.U.... Post K.D.2004IGF1
31Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal. (14671148)Parkinson C.... Trainer P.J.2003IGF1, GHR, CD36
32Elevated circulating somatostatin levels in acromegaly. (12952361)Arosio M.... Peracchi M.2003SST
33Development of acromegaly in patients with prolactino mas. (12824861)Andersen M.... Hagen C.2003PRL, GH1
34Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study. (11207632)Katznelson L.... Stravou S.2001PRL, GH1
35Failure of radiotherapy in acromegaly. (11720896)Cozzi R.... Attanasio R.2001GH1
36Long-term effects of depot long-acting somatostatin a nalog octreotide on hormone levels and tumor mass in acromegaly. (11397887)Colao A.... Lombardi G.2001GH1
37Current management of acromegaly. (11249504)DA-ez J.J.... Iglesias P.2000SST
38Efficacy and tolerability of the long-acting somatost atin analog lanreotide in acromegaly. A 12-month multicenter study of 58 acrome galic patients. French Multicenter Study Group on Lanreotide in Acromegaly. (11081148)Chanson P.... Schaison G.2000IGF1
39Use of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in the diagnosis of acromegaly and growth hormone deficiency in adults. (8971551)Thissen J.P.... Maiter D.1996IGF1, IGFBP3
40Relationship between fasting glycemia, serum peptide C, insulin, growth hormone and plasma glucagon in acromegaly (9005421)Piniewska-HuA8as D.... Bonicki W.1996INS
41Effects of acromegaly treatment and growth hormone on adipose tissue lipoprotein lipase. (7593431)Simsolo R.B.... Kern P.A.1995LPL
42Inverse correlation between insulin-like growth factor binding protein-1 and insulin in patients with acromegaly during treatment with the somatostatin analogue octreotide. (7525123)Fredstorp L.... Hall K.1994IGF1, INS, IGFBP1
43ACTH secretion, circadian variations of salivary free and total serum cortisol and urinary 17-OHCS excretion in active acromegaly following bromocriptine treatment. (7949021)Ostrowska Z.... Buntner B.1994IGF1, GH1
44G-proteins and endocrine tumors. The example of acromegaly (7939340)Chabre O.1994ADCY10, GHRH
45The evaluation of hypothalamic somatostatin tone using pyridostigmine and thyrotropin releasing hormone in patients with acromegaly. (7915736)Hanew K.... Abe K.1994SST
46Octreotide long term treatment of acromegaly: effect of drug withdrawal on serum growth hormone/insulin-like growth factor-I concentrations and on serum gastrin/24-hour intragastric pH values. (8325938)PlAPckinger U.... Quabbe H.J.1993IGF1, GH1, GAST
47Measurement of insulin-like growth factor I (IGF-I) in normal adults, patients with liver cirrhosis and acromegaly: experience with a new competitive enzyme immunoassay. (8223982)Kratzsch J.... Rotzsch W.1993IGF1
48Acromegaly with hyperprolactinemia developed after bilateral adrenalectomy in a patient with Cushing's syndrome due to adrenocortical nodular hyperplasia. (7951491)Ogo A.... Ibayashi H.1993POMC, PRL
49Rheumatologic and skeletal changes in acromegaly. (1521515)Lieberman S.A.... Hoffman A.R.1992IGF1
50Inter-relations between growth hormone, insulin, insulin-like growth factor-I (IGF-I), IGF-binding protein-1 (IGFBP-1) and sex hormone-binding globulin in acromegaly. (1715247)Holly J.M.... Wass J.A.1991IGF1, PRL, INS

Expression for genes affiliated with Acromegaly

Sources:
1BioGPS
See all sources
Expression patterns in normal tissues for genes affiliated with Acromegaly

Pathways for genes affiliated with Acromegaly

Sources:
41Thomson Reuters, 36QIAGEN, 38Reactome, 37R&D Systems, 10EMD Millipore, 20KEGG
See all sources

Pathways related to acromegaly according to GeneDecks:

(show top 50)    (show all 73)
idPathwayScoreTop Affiliating Genes
1Development_Leptin signaling via JAK/STAT and MAPK cascades4110.9TRH, LEPR
2Glioma Invasiveness3610.6TGFA, GHRH, GH1, GNRH1
3Class A/1 (Rhodopsin-like receptors)3810.6GAL, NPY, SSTR5, SSTR4, SSTR3, SSTR2
4Class B/2 (Secretin family receptors)3810.6CRH, PTH, GHRHR, GHRH, CALCA, GNAS
5Adipocytokines & Insulin Signaling3710.5ADIPOQ, INSR, INS, LEP, NAMPT, RBP4
6Neuropeptides signaling through G-protein alpha-i & G-protein alpha-q1010.5GAL, NPY, AGTR1, SSTR5, SSTR4, SSTR3
7Development Leptin signaling via JAK/STAT and MAPK cascades1010.4POMC, CRP, TRH, LEPR, LEP
8Selected targets of CREB11010.4GAL, CRH, CCK, INS, GCG
9Neuroactive ligand-receptor interaction2010.4LEP, ADRB2, PRL, PRLR, AGTR1, SSTR5
10Disease3810.4PRL, KLK3, IGF1, IGFBP3, IGFALS, IGFBP2
11Breast Cancer Regulation by Stathmin13610.4TGFA, EGF, GHRH
12eNOS Signaling3610.2PRKAR1A, TGFA, GHRH, GH1, GNRH1, IGF2
1314-3-3 Induced Intracellular Signaling3610.2TNF, GHRH, GH1, GNRH1, IGF1, INSR
14Development IGF-RI signaling1010.2IGF1, IGFBP3, IGFBP2, IGF2, IGFBP1, IGFBP5
15G alpha (q) signalling events3810.1TRHR, EDN1, AGTR1, GAST, TRH, GHSR
16Adipocytokine signaling pathway209.9ADIPOQ, NPY, POMC, TNF, CD36, LEPR
17Blood Coagulation Signaling Pathways379.9TFPI, THBD, PLAT, SERPINE1, SERPINC1
18Cell adhesion_ECM remodeling419.7MMP2, IL8, IGF2, IGF1, PLAT, KLK3
19Cell adhesion ECM remodeling109.7KLK3, SERPINE1, MMP2, IL8, IGF2, IGF1
20Selected targets of GCR-alpha109.7THBD, TRHR, GHSR, GHR, IGFBP1, IL8
21Akt Signaling369.7TNF, IL6
22mTOR Pathway369.7TGFA, EGF, GHRH, GH1, GNRH1, IGF1
23eIF2 Pathway369.6TGFA, EGF, GHRH, GH1, GNRH1, IGF1
24Nanog in Mammalian ESC Pluripotency369.6GH1, GHRH, EGF, TGFA, GNRH1, IGF1
25p70S6K Signaling369.6TGFA, EGF, GHRH, GH1, GNRH1, IGF1
26Renin-Angiotensin Pathway369.5PRKAR1A, TGFA, AGTR1, AGT, ACE, GHRH
27Transcription_Role of VDR in regulation of genes involved in osteoporosis419.5PTH, TNF, CALCA, IGF1, IL6, BGLAP
28PPAR Pathway369.5PPARG, TNF, GH1, IGF1, IGF2, IL6
29Rap1 Pathway369.5PRKAR1A, TGFA, EGF, GHRH, GH1, GNRH1
30Selected targets of C/EBPalpha109.5ADIPOQ, ALB, APOB, CD36, SERPINC1, RETN
31Prostate cancer209.4TGFA, EGF, KLK3, TP53, IGF1, INS
32Transcription Role of VDR in regulation of genes involved in osteoporosis109.4PTH, TNF, CALCA, IGF1, IL6, BGLAP
33NF-KappaB (p50-p65) Pathway369.3PRKAR1A, TGFA, EGF, TNF, GHRH, GH1
34Selected targets of HNF1109.3CRP, ALB, IGFBP1, APOB, APOA1, INS
35Nuclear Receptor Activation by Vitamin-A369.3PRKAR1A, TGFA, EGF, GHRH, GH1, GNRH1
36p53 Mediated Apoptosis369.2TGFA, EGF, TP53, GHRH, GH1, GNRH1
37Mitochondrial Apoptosis369.2TGFA, EGF, TP53, GHRH, GH1, GNRH1
38Activation of PKA through GPCR369.2PYGM, CRP, TGFA, PRKAR1A, ADRB2, GHRH
39NF-KappaB Family Pathway369.1TGFA, EGF, TNF, GHRH, GH1, GNRH1
40JAK-STAT Pathway369.1EGF, AGT, AGTR1, TGFA, PRLR, PRL
41Pathways in cancer208.9TGFA, EGF, TP53, MMP2, CDKN1B, VEGFA
42Activation of cAMP-Dependent PKA368.9PYGM, CRP, EGF, TGFA, PRKAR1A, ADRB2
43Apoptotic Pathways in Synovial Fibroblasts368.9TGFA, EGF, TNF, TP53, GHRH, GH1
44Cellular Apoptosis Pathway368.8TGFA, EGF, TNF, TP53, GHRH, GH1
45Immune response IL-1 signaling pathway108.7CP, EDN1, TNF, IL8, IL6, SERPINE1
46cAMP Pathway368.7ADRB2, PRKAR1A, TGFA, EGF, CRP, PYGM
47Pancreatic Adenocarcinoma368.7TGFA, EGF, TP53, GHRH, GH1, GNRH1
48Immune response_IL-1 signaling pathway418.7CP, EDN1, TNF, IL8, IL6, SERPINE1
49Cytokine-cytokine receptor interaction208.6TNF, EGF, PRLR, PRL, GHR, GH1
50p38 Signaling368.0EGF, TNF, TP53, GHRH, GH1, GNRH1

Compounds for genes affiliated with Acromegaly

Sources:
32Novoseek , 18HMDB, 9DrugBank, 42Tocris Bioscience, 34PharmGKB
See all sources

Compounds related to acromegaly according to GeneDecks:

(show top 50)    (show all 519)
idCompoundScoreTop Affiliating Genes
125-hydroxyvitamin d32 10.5GC, BGLAP, SCG5, LEP, IGFBP5, PTH
217-hydroxyprogesterone32 18 11.5RETN, PBX1, IGFBP1, IGFBP2, GNRH1, CYP11B2
3metoclopramide32 9 9 12.4PBX1, MLN, CCK, GNRH1, GH1, TRH
4triiodothyronine32 10.3RBP4, LEP, LEPR, IGFBP1, IGF2, IGFBP3
5clomiphene citrate32 10.2CGB, INS, INSR, IGFBP1, IGFBP3, IGF1
6dehydroepiandrosterone sulfate32 10.1RBP4, LEP, INS, IGFBP1, IGF2, IGFBP3
7carbohydrates32 10.1CFI, IL1RN, CCK, GHR, PYY, THBD
8opiate32 10.1CCK, GNRH1, GH1, GHRH, GHRL, DRD2
92-deoxyglucose32 10.1INS, INSR, IGF2, IGF1, CALCA, GHRL
10atropine32 9 9 11.9GCG, VIP, MLN, CCK, CALCA, GH1
11gnrh32 9.6GCG, SERPINE1, PBX1, LEP, LEPR, CGB
12cortisone32 18 10.5LEP, INS, IGF1, HSD11B2, HSD11B1, GH1
13gaba32 42 10.4GCG, VIP, CHGA, INSR, IL1RAPL2, CCK
14orlistat32 42 9 9 12.4GCG, LPL, LEP, INS, APOB, CCK
15raloxifene32 9 9 11.4SERPINC1, SERPINE1, BGLAP, CD36, CDKN1B, APOA1
16progesterone32 42 9 18 9 13.4RBP4, PBX1, LEPR, CHGA, CGB, CDKN1B
17corticosterone32 18 10.3GCG, VIP, BGLAP, LEPR, IL1RAPL2, IL1RN
18l-nmma32 9.3VIP, INSR, IL1RN, CCK, GH1, GHRL
19verapamil32 34 9 18 9 13.3VIP, NAGLU, MLN, INSR, APOB, GPT
20estrone32 9 18 9 12.2LPL, BGLAP, LEP, APOB, IGFBP1, IGF2
21glycerol32 9 18 9 12.1GCG, SERPINC1, LPL, LEP, CD36, MMP2
22pravastatin32 34 9 18 9 13.0SERPINE1, LPA, IL6, APOA1, APOB, CRP
23h2o232 9.0VIP, NAGLU, LPA, BGLAP, LEP, LEPR
24chloramphenicol32 9 9 10.9GC, SERPINC1, SERPINE1, LPL, CHGA, INSR
25spironolactone32 42 34 9 9 12.7SERPINE1, ALB, GNRH1, HSD11B2, CYP11B2, CRH
26captopril32 42 9 9 11.6VIP, MMP2, APOA1, APOB, ALB, CALCA
27glutamate32 8.6GCG, GC, VIP, SCG5, LEP, LEPR
28vitamin a32 9 18 9 11.5RETN, GC, RBP4, NAGLU, LPL, LEP
29pge232 8.4VIP, IL1RAPL2, IL1RN, APC, APOA1, CCK
305-hydroxytryptamine32 8.4GCG, SERPINE1, VIP, CHGA, MLN, IL1RAPL2
31arginine32 8.2GCG, SERPINC1, VIP, LPA, PBX1, BGLAP
32homocysteine32 18 9.2RETN, SERPINC1, SERPINE1, NAGLU, LPA, APOA1
33prostaglandin32 8.1VIP, IL1RAPL2, IL1RN, IL6, IGFBP5, HSD11B2
34folate32 8.0RBP4, SERPINC1, LPA, MMP2, APC, APOB
35epinephrine32 9 18 9 10.8GCG, VIP, LEP, CHGA, MMP2, INS
36cysteine32 7.8GCG, RBP4, NAGLU, LPA, BGLAP, SCG5
37troglitazone32 42 9 9 10.6SERPINE1, LPL, LEP, CD36, CDKN1B, MMP2
38candesartan32 9 9 9.6SERPINE1, VEGFA, MMP2, ALB, PPARG, KLK3
39testosterone32 9 18 9 10.1GC, SERPINC1, VIP, LPL, PBX1, BGLAP
40methotrexate32 34 42 9 9 10.9SERPINE1, NAGLU, LEP, CGB, CDKN1B, MMP2
41thyroxine32 18 7.9RETN, GC, RBP4, VIP, LPA, LPL
42thymidine32 18 7.7VIP, NAGLU, SCG5, LEPR, CDKN1B, INSR
43simvastatin32 34 42 9 18 9 11.7RBP4, SERPINE1, VEGFA, LPA, LPL, BGLAP
44sb 20358032 42 7.3GCG, VEGFA, BGLAP, CD36, CDKN1B, MMP2
45creatinine32 6.3RETN, GCG, GC, RBP4, SERPINC1, NAGLU
46vitamin d32 6.0GC, SERPINE1, NAGLU, LPL, BGLAP, SCG5
47indomethacin32 9 9 7.9GCG, VIP, LPL, LEP, IL1RAPL2, IL1RN
48alanine32 5.5RETN, GCG, RBP4, SERPINC1, VIP, NAGLU
49cholesterol32 9 18 9 8.1RETN, GC, RBP4, SERPINE1, NAGLU, NAMPT
50lactate32 4.7GCG, RBP4, VIP, NAGLU, LPL, CHGA

GO Terms for genes affiliated with Acromegaly

Sources:
12Gene Ontology
See all sources

Cellular components related to acromegaly according to GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1insulin-like growth factor binding protein complexGO:01694210.4IGF1, IGFBP3, IGFBP5
2endosome lumenGO:03190410.0INS, APOB, PRLR
3secretory granuleGO:0301419.4GCG, VEGFA, SCG5, CHGA, INS, APOA1
4cell surfaceGO:0099868.8PRLR, TGFA, THBD, PLAT, TNF, TRHR
5platelet alpha granule lumenGO:0310938.7SERPINE1, VEGFA, IGF1, ALB, EGF
6plasma membraneGO:0058866.9SSTR5, SSTR4, SSTR3, SSTR2, SSTR1, DRD2
7extracellular regionGO:0055763.5RETN, INS, IL6, IL8, APOA1, APOB
8extracellular spaceGO:0056153.3GC, IGF2, IGFBP2, IGFALS, IGFBP3, IGF1

Biological processes related to acromegaly according to GeneDecks:

(show top 50)    (show all 66)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of insulin-like growth factor receptor signaling pathwayGO:04356810.9GHSR, GHRHR, GHRH, GH1, IGF1, IGFBP3
2growth hormone secretionGO:03025210.9GAL, GHSR, GHRL, GHRHR, GHRH
3somatostatin signaling pathwayGO:03817010.8SSTR5, SSTR4, SSTR3, SSTR2, SSTR1
4positive regulation of growth hormone secretionGO:06012410.8DRD2, GHRL, GHRHR, GHRH
5response to foodGO:03209410.8GHSR, GHRH, GHR, HSD11B2
6positive regulation of multicellular organism growthGO:04001810.8AGT, DRD2, GHSR, GHRL, GHRHR, GHRH
7induction of apoptosis by hormonesGO:00862810.7CRH, SSTR3, SST, PTH
8G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerGO:00718710.7NPY, SSTR5, SSTR4, SSTR3, SSTR2, SSTR1
9positive regulation of glycogen biosynthetic processGO:04572510.6PTH, IGF1, IGF2, INSR, INS
10negative regulation of smooth muscle cell migrationGO:01491210.6ADIPOQ, IGFBP3, IGFBP5, SERPINE1
11adult feeding behaviorGO:00834310.6NPY, GHSR, GHRL, LEP
12response to insulin stimulusGO:03286810.6GGH, GAL, GHRHR, HSD11B2, LEP, RBP4
13positive regulation of glucose importGO:04632610.6ADIPOQ, PTH, IGF1, INSR, INS
14response to ethanolGO:04547110.5GGH, ADIPOQ, TRH, GNRH1, INSR, BGLAP
15female pregnancyGO:00756510.4PRL, THBD, CRH, HSD11B2, GNRH1, GNAS
16feeding behaviorGO:00763110.4GAL, NPY, CRH, PYY, DRD2, CALCA
17positive regulation of cAMP biosynthetic processGO:03081910.3PTH, GHRHR, GHRH, CALCA, GCG
18negative regulation of inflammatory responseGO:05072810.3ADIPOQ, ADRB2, GHSR, GHRL, APOA1, SERPINC1
19positive regulation of appetiteGO:03210010.3NPY, GHSR, GHRL
20negative regulation of smooth muscle cell proliferationGO:04866210.2ADIPOQ, NPPB, PPARG, IGFBP3, IGFBP5
21glucose metabolic processGO:00600610.2ADIPOQ, PYGM, TNF, GHRL, IGF2, IGFBP5
22response to estrogen stimulusGO:04362710.2GAL, PPARG, GHRL, GHRHR, BGLAP, SERPINE1
23regulation of insulin secretionGO:05079610.2PRKAR1A, SSTR5, TNF, GNAS, INS, LEP
24positive regulation of cellular protein metabolic processGO:03227010.1ADIPOQ, AGTR1, AGT, INS
25glucose homeostasisGO:04259310.1ADIPOQ, PPARG, SSTR5, IGFBP5, INSR, INS
26cellular response to insulin stimulusGO:03286910.1ADIPOQ, PPARG, GHSR, GHRHR, GHR, INSR
27positive regulation of protein kinase B signaling cascadeGO:05189710.0TNF, IGF1, IGF2, IGFBP5, INSR, INS
28positive regulation of macrophage derived foam cell differentiationGO:01074410.0AGTR1, AGT, APOB, CD36, LPL
29positive regulation of renal sodium excretionGO:03581510.0DRD2, EDN1, AGT, NPPB
30cell surface receptor signaling pathwayGO:0071669.9ADRB2, NPPB, PRL, PRLR, EDN1, SSTR1
31regulation of blood pressureGO:0082179.8NPPB, POMC, ACE, PPARG, CALCA, CHGA
32cell-cell signalingGO:0072679.8NAMPT, POMC, AGT, EDN1, SSTR3, SSTR2
33elevation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathwayGO:0514829.8AGTR1, EDN1, DRD2, CALCA
34positive regulation of MAPK cascadeGO:0434109.6ADRB2, AGT, IGF1, IGFBP3, IGF2, IL6
35regulation of vasoconstrictionGO:0192299.6EDN1, ACE, AGT, AGTR1
36positive regulation of apoptotic processGO:0430659.5GAL, ADCY10, ADRB2, AGT, TNF, TP53
37positive regulation of mitosisGO:0458409.5TGFA, EGF, EDN1, TNF, IGF1, IGF2
38signal transductionGO:0071659.2TRHDE, TRH, PPARG, CRH, EGF, TG
39response to glucocorticoid stimulusGO:0513849.1GHR, GHRHR, TNF, PLAT, ADIPOQ, HSD11B2
40G-protein coupled receptor signaling pathwayGO:0071869.1PTH, SST, SSTR4, SSTR5, EDN1, AGT
41response to drugGO:0424938.9PPARG, EDN1, TGFA, NPPB, GAL, GGH
42positive regulation of peptidyl-tyrosine phosphorylationGO:0507318.8GH1, GHR, TP53, AGT, ADIPOQ, IGF1
43response to hypoxiaGO:0016668.7ADIPOQ, NPPB, EDN1, PLAT, CRP, PYGM
44platelet degranulationGO:0025768.6EGF, ALB, IGF1, APOA1, CD36, VEGFA
45positive regulation of cell proliferationGO:0082848.5IGF2, IGF1, GHRH, GHRHR, EDN1, EGF
46negative regulation of cell proliferationGO:0082858.5SST, SSTR1, SSTR2, SSTR3, SSTR4, SSTR5
47small molecule metabolic processGO:0442818.2ALB, GNAS, HSD11B1, PYGM, CYP11B2, SMS
48lipid metabolic processGO:0066298.1PPARG, ALB, APOB, APOA1, IL1RN, CD36
49blood coagulationGO:0075967.6TP53, PLAT, EGF, THBD, TFPI, PRKAR1A
50negative regulation of apoptotic processGO:0430667.2TNF, TP53, GHRL, ALB, APC, IL6

Molecular functions related to acromegaly according to GeneDecks:

(show all 12)
idNameGO IDScoreTop Affiliating Genes
1somatostatin receptor activityGO:00499410.6SSTR5, SSTR4, SSTR3, SSTR2, SSTR1
2insulin-like growth factor I bindingGO:03199410.5IGFBP3, IGFBP2, IGFBP5, INSR
3neuropeptide hormone activityGO:00518410.4GAL, NPY, CORT, CRH, PYY, TRH
4insulin-like growth factor II bindingGO:03199510.4INSR, IGFBP2, IGFBP3
5insulin-like growth factor receptor bindingGO:00515910.3IGF1, IGF2, INSR, INS
6fibronectin bindingGO:0019689.6IGFBP3, IGFBP5, LPA, VEGFA
7receptor bindingGO:0051029.5ADIPOQ, NPY, NPPB, POMC, CRH, CALCA
8protease bindingGO:0020209.2SERPINC1, SERPINE1, INS, TP53, TNF
9hormone activityGO:0051799.2RETN, PTH, SST, CRH, EDN1, AGT
10drug bindingGO:0081449.0ADRB2, ACE, PPARG, PYGM, DRD2, ALB
11growth factor activityGO:0080838.9TGFA, AGT, EGF, GH1, IGF1, IGF2
12protein bindingGO:0055153.6PPARG, SSTR3, SSTR2, DRD2, DYM, TNF

Sources for Acromegaly

2CDC
11FMA
18HMDB
19ICD9CM
20KEGG
24MeSH
25MGI
27NCIt
28NDF-RT
31NINDS
32Novoseek
33OMIM
35PubMed
36QIAGEN
43UMLS